the efficacy, tolerance and nutritional effect of different HF. pHF may offer a beneficial preventive effect on eczema in formula-fed newborns with a family risk of atopy. eHF is tolerated by 90% of infants with CMA and is the treatment of choice in all except severe cases of CMA. Promising results were recently obtained with eHRPF. Nutritional adequacy of the HF should be carefully evaluated to ensure appropriate growth in allergic infants. A proper diagnostic approach and follow-up are necessary to avoid unnecessary or excessively prolonged use of HF.
Disclosure Statement
Y.V. is consultant for ASPEN, Biocodex and United Pharmaceuticals. S.S. has participated as a consultant and/or speaker for Arla Foods, Danone/Nutricia, IMS Health, Menarini, Milte and Nestlé.
References
1 Koletzko S, Niggemann B, Arato A, et al: Diagnostic approach and management of cow’s milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr 2012;55:221-229.
2 Muraro A, Halken S, Arshad SH, et al: EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy 2014;69:590-601.
3 Fiocchi A, Schünemann HJ, Brozek J, et al: Diagnosis and rationale for action against cow’s milk allergy (DRACMA): a summary report. J Allergy Clin Immunol 2010;126:1119-1128.
4 Du Toit G, Roberts G, Sayre PH, et al: Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 2015;372:803-813.
5 Nwaru BI, Hickstein L, Panesar SS, et al: Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy 2014;69:992-1007.
6 Perez-Machado MA, Ashwood P, Thomson MA, et al: Reduced transforming growth factor-beta1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 2003;33:2307-2315.
7 Tsabouri S, Douros K, Priftis KN: Cow’s milk allergenicity. Endocr Metab Immune Disord Drug Targets 2014;14:16-26.
8 Spuergin P, Walter M, Schiltz E, et al: Allergenicity of alpha-caseins from cow, sheep, and goat. Allergy 1997;52:293-298.
9 Mills EN, Mackie AR: The impact of processing on allergenicity of food. Curr Opin Allergy Clin Immunol 2008;8:249-253.
10 Thomas K, Herouet-Guicheney C, Ladics G, et al: Evaluating the effect of food processing on the potential human allergenicity of novel proteins: international workshop report. Food Chem Toxicol 2007;45:1116-1222.
11 El Mecherfi KE, Saidi D, Kheroua O, et al: Combined microwave and enzymatic treatments for β-lactoglobulin and bovine whey proteins and their effect on the IgE immunoreactivity. Eur Food Res Technol 2011;233:859-867.
12 Peñas E, Préstamo G, Baeza ML, et al: Effects of combined high pressure and enzymatic treatments on the hydrolysis and immunoreactivity of dairy whey proteins. Int Dairy J 2006;16:831-839.
13 Pescuma M, Hébert EM, Rabesona H, et al: Proteolytic action of Lactobacillus delbrueckii subsp. bulgaricus CRL 656 reduces antigenic response to bovine β-lactoglobulin. Food Chem 2011;127:487-492.
14 Ahmadova A, El-Ghaish S, Choiset Y, et al: Modification of IgE binding to β- and αS1-caseins by proteolytic activity of Lactobacillus helveticus A75. J Food Biochem 2012;37:491-500.
15 El-Ghaish S, Rabesona H, Choiset Y, et al: Proteolysis by Lactobacillus fermentum IFO3956 isolated from Egyptian milk products decreases immunoreactivity of αS1-casein. J Dairy Res 2011;9:1-8.
16 Vandenplas Y, Bathia J, Shamir R, et al: Hydrolyzed formulas for allergy prevention. J Pediatr Gastroenterol Nutr 2014;58:549-552.
17 Greer FR, Sicherer SH, Burks AW, American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Section on Allergy and Immunology: Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008;121:183-191.
18 Aas K: What makes an allergen an allergen? Allergy 1978;33:3-14.
19 van Beresteijn ECH, Peeters RA, Kaper J, et al: Molecular mass distribution, immunological properties and nutritive value of whey protein hydrolysates. J Food Protection 1994;57:619-625.
20 Puerta A, Diez-Masa JC, de Frutos M: Immunochromatographic determination of β-lactoglobulin and its antigenic peptides in hypoallergenic formulas. Int Dairy J 2006;16:406-414.
21 Selo I, Clemen TG, Bernard H, et al: Allergy to bovine β-lactoglobulin: specificity of human IgE to tryptic peptides. Clin Exp Allergy 1999;29:1055-1063.
22 Calvo MM, Gómez R: Peptidic profile, molecular mass distribution and immunological properties of commercial hypoallergenic infant formulas. Milchwissenschaft 2002;57:187-190.
23 Kneepkens CMF, Meijer Y: Clinical practice. Diagnosis and treatment of cow’s milk allergy. Eur J Pediatr 2009;168:891-896.
24 Vandenplas Y, Cruchet S, Faure C, et al: When should we use partially hydrolysed formulae for frequent gastro-intestinal symptoms and allergy prevention? Acta Paediatr 2014;103:689-695.
25 Zeiger RS: Food allergen avoidance in the prevention of food allergy in infants and children. Pediatrics 2003;111:1662-1671.
26 Osborn DA, Sinn J: Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev 2006;4:CD003664.
27 Fuertes E, Standl M, von Berg A, Lehmann I: Parental allergic disease before and after child birth poses similar risk for childhood allergies. Allergy 2015;70:873-876.
28 Alexander